Palomar director exercises 1,278 stock options at $23.46

Palomar Holdings, Inc. reported that one of its directors exercised stock options to acquire 1,278 shares of common stock on December 12, 2025 at an exercise price of $23.46 per share.

Rhea-AI Filing Summary

Palomar Holdings, Inc. reported that one of its directors exercised stock options to acquire 1,278 shares of common stock on December 12, 2025 at an exercise price of $23.46 per share.

After this transaction, the director beneficially owned 8,051 shares of common stock and 2,984 stock options, all held directly. The exercised options relate to a grant where 50% of the shares vested on May 21, 2020 and the remaining shares vested in twelve equal successive monthly installments, and the option carries an expiration date of May 21, 2029.

Insider Trade Summary

1,278 shares exercised/converted

Exercise 2 txns

Insider Fallon Catriona M

Role Director

Type	Security	Shares	Price	Value
Exercise	Stock Option (right to buy)	1,278	$0.00	$0.00
Exercise	Common Stock	1,278	$23.46	$30K

Holdings After Transaction: Stock Option (right to buy) — 2,984 contracts (Direct); Common Stock — 8,051 shares (Direct)

Footnotes (1)

1. F1. Fifty percent (50%) of the option shares vested and became exercisable on May 21, 2020 and the remaining option shares vested and became exercisable in twelve (12) equal successive monthly installments thereafter.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did a Palomar Holdings, Inc. (PLMR) director report?

A director of Palomar Holdings, Inc. reported exercising a stock option and acquiring 1,278 shares of the company’s common stock.

How many Palomar (PLMR) shares were acquired and at what price?

The director acquired 1,278 shares of Palomar common stock at an exercise price of $23.46 per share.

What is the director’s Palomar share ownership after the transaction?

Following the option exercise, the director beneficially owned 8,051 shares of Palomar common stock, held directly.

How many Palomar stock options does the director still hold after this filing?

After the reported transaction, the director held 2,984 stock options on a direct basis.

What were the key terms of the exercised Palomar stock option?

The exercised stock option had an exercise price of $23.46 per share, covered 1,278 underlying shares of common stock, and has an expiration date of May 21, 2029.

How did the Palomar (PLMR) stock option vest for this director?

According to the disclosure, 50% of the option shares vested and became exercisable on May 21, 2020, and the remaining shares vested in twelve equal successive monthly installments thereafter.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/15/2025 - 04:15 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fallon Catriona M

(Last) (First) (Middle)

7979 IVANHOE AVENUE, SUITE 500

(Street)

LA JOLLA CA 92037

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Palomar Holdings, Inc. [ PLMR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/12/2025		M		1,278	A	$23.46	8,051	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$23.46	12/12/2025		M			1,278	(1)	05/21/2029	Common Stock	1,278	$0	2,984	D

Explanation of Responses:

1. Fifty percent (50%) of the option shares vested and became exercisable on May 21, 2020 and the remaining option shares vested and became exercisable in twelve (12) equal successive monthly installments thereafter.

Remarks:

	/s/ Angela Grant, Attorney-in-Fact	12/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.